World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
USA
2026

D-Index & Metrics

Molecular Biology

D-Index
137
Citations
95292
World Ranking
139
National Ranking
89

Biology and Biochemistry

D-Index
143
Citations
101072
World Ranking
235
National Ranking
161

David R. Liu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where David R. Liu sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 435 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

David R. Liu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where David R. Liu sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 137 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in United States Leader Award
  • 2020 - Member of the National Academy of Medicine (NAM)
  • 2020 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2006 - ACS Award in Pure Chemistry, American Chemical Society (ACS)
  • 2002 - Fellow of Alfred P. Sloan Foundation

Overview

David R. Liu is affiliated with the Broad Institute in the United States. Their research primarily spans the field of Biochemistry, Genetics, and Molecular Biology, with significant contributions to Molecular Biology, Genetics, Immunology, Epidemiology, and Oncology.

The scientist's main research topics include:

  • CRISPR and Genetic Engineering
  • RNA regulation and disease
  • Virus-based gene therapy research
  • RNA and protein synthesis mechanisms
  • Advanced biosensing and bioanalysis techniques
  • RNA Interference and Gene Delivery
  • Cytomegalovirus and herpesvirus research

Frequent co-authors in their work have been:

  • Gregory A. Newby
  • Aditya Raguram
  • Jessie R. Davis
  • Jonathan M. Levy
  • Luke W. Koblan

David R. Liu's publications have appeared predominantly in the following venues:

  • Nature Biotechnology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature Biomedical Engineering
  • Cell

Notable recent papers include:

  • Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors, 2020, Nature Biotechnology
  • Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity, 2020, Nature Biotechnology
  • Prime genome editing in rice and wheat, 2020, Nature Biotechnology
  • Enhanced prime editing systems by manipulating cellular determinants of editing outcomes, 2021, Cell
  • A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing, 2020, Nature

David R. Liu has been recognized with several awards including being named a Fellow of the American Association for the Advancement of Science (AAAS) in 2020 and a Fellow of the Alfred P. Sloan Foundation in 2002.

Best Publications

  • Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

    Mamta V. Tahiliani;Kian Peng Koh;Yinghua Shen;William Abraham Pastor

  • Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

    Alexis C. Komor;Yongjoo B. Kim;Yongjoo B. Kim;Michael S. Packer;Michael S. Packer;John A. Zuris;John A. Zuris

  • Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage

    Nicole M. Gaudelli;Alexis C. Komor;Holly A. Rees;Holly A. Rees;Holly A. Rees;Michael S. Packer

  • Search-and-replace genome editing without double-strand breaks or donor DNA

    Andrew V. Anzalone;Andrew V. Anzalone;Andrew V. Anzalone;Peyton B. Randolph;Peyton B. Randolph;Peyton B. Randolph;Jessie R. Davis;Jessie R. Davis;Jessie R. Davis;Alexander A. Sousa;Alexander A. Sousa;Alexander A. Sousa

  • DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists

    Da Wei Huang;Brad T. Sherman;Qina Tan;Joseph Kir

  • Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

    Eugene D. Kwon;Charles G. Drake;Howard I. Scher;Karim Fizazi

  • High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

    Vikram Pattanayak;Steven Lin;John P Guilinger;Enbo Ma

  • Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

    Andrew V. Anzalone;Luke W. Koblan;Luke W. Koblan;Luke W. Koblan;David R. Liu;David R. Liu;David R. Liu

  • Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

    John A. Zuris;David B. Thompson;Yilai Shu;John Paul Guilinger

  • Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

    Johnny H. Hu;Shannon M. Miller;Shannon M. Miller;Shannon M. Miller;Maarten H. Geurts;Maarten H. Geurts;Maarten H. Geurts;Weixin Tang;Weixin Tang;Weixin Tang

  • A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

    Livnat Jerby-Arnon;Parin Shah;Michael S. Cuoco;Christopher Rodman

  • Base editing: precision chemistry on the genome and transcriptome of living cells

    Holly A. Rees;David R. Liu;David R. Liu;David R. Liu

  • Sequence-controlled polymers.

    Jean-François Lutz;Makoto Ouchi;David R. Liu;Mitsuo Sawamoto

  • CRISPResso2 provides accurate and rapid genome editing sequence analysis.

    Clement K;Rees H;Canver Mc;Canver Mc;Gehrke Jm

  • CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

    Alexis C. Komor;Alexis C. Komor;Alexis C. Komor;Ahmed H. Badran;Ahmed H. Badran;Ahmed H. Badran;David R. Liu;David R. Liu;David R. Liu

  • Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification

    John Paul Guilinger;David B. Thompson;David B. Thompson;David R. Liu;David R. Liu

  • Methods for the directed evolution of proteins

    Michael S. Packer;David R. Liu

  • A Small Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog

    Justin K. Ichida;Joel Blanchard;Kelvin Lam;Esther Y. Son

  • The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing

    Yun Huang;William A. Pastor;Yinghua Shen;Mamta Tahiliani

  • Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

    Philip J. Johnson;Shukui Qin;Joong Won Park;Ronnie T.P. Poon

Frequent Co-Authors

Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Peter G. Schultz
Peter G. Schultz Scripps Research Institute
Christine D. Wilson
Christine D. Wilson McMaster University
Lei Wang
Lei Wang University of California, San Francisco
Eric Meggers
Eric Meggers Philipp University of Marburg
Jason W. Chin
Jason W. Chin MRC Laboratory of Molecular Biology
Michael A. Fischbach
Michael A. Fischbach Stanford University
Christopher T. Walsh
Christopher T. Walsh Stanford University
Levi A. Garraway
Levi A. Garraway Roche (United States)
J. Keith Joung
J. Keith Joung Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing David R. Liu

Trending Scientists

Recently Published Articles